"Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Amel" by Amir Toor MD
 

Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Ameliorates the Cytokine Milieu and Endothelial Injury Following Myeloablative Conditioning

Publication/Presentation Date

3-2020

Volume

26

Issue

3

First Page

139

Last Page

140

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article

Share

COinS